重組蛋白市場：依產品類型、表現系統、應用、最終用戶和地區分類

2026年重組蛋白市場規模預計為43.479億美元，預計到2033年將達到94.331億美元。預計2026年至2033年，該市場將以11.7%的複合年成長率成長。

重組蛋白是由克隆到表達載體中的重組DNA編碼的蛋白質，這些表達載體能夠實現基因表現和傳訊RNA翻譯。利用重組DNA技術進行基因改造可以產生突變蛋白。重組蛋白是天然蛋白的修飾版本，透過多種方式生產，以提高蛋白質產量、改變基因序列並生產有用的產品。

許多重組蛋白需要並且能夠進行糖基化等轉譯後修飾，但這些修飾只能在真核生物、酵母、哺乳動物和昆蟲細胞培養系統中進行。 HEK293衍生細胞株用於瞬時蛋白表現。目前，大多數重組治療性蛋白質在哺乳動物細胞中生產，因為哺乳動物細胞能夠生產與天然蛋白質相似的高品質蛋白質。此外，許多已通過核准的重組治療性蛋白質在大腸桿菌中生產，因為大腸桿菌的遺傳特性已被充分了解，生長迅速，且產量高。

市場動態

該公司正專注於透過收購和合作等策略，在全球市場確立穩固地位。例如，2022年12月，賽默飛世爾科技收購了重組蛋白研發和生產商Peprotec公司。此次收購將協助賽默飛世爾科技強化其重組蛋白產品組合。

預計重組激素生技藥品核准核准數量的不斷增加將推動預測期內的市場成長。例如，2022年1月，跨國製藥和生物技術公司輝瑞和生物技術公司OPKO Health宣布，美國食品藥物管理局（FDA）已就其針對Somatologun的生技藥品核准申請（BLA）發出完整回复函（CRL）。 Somatologun是一種在臨床實驗藥物，為長效重組人體生長荷爾蒙，每週給藥一次，用於治療兒童生長激素缺乏症（GHD）。

本次調查的主要特點

• 本研究揭示了各個細分市場的潛在商機，並說明了該市場極具吸引力的投資提案矩陣。
• 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
• 本研究基於以下參數對全球重組蛋白市場的主要參與者進行了概況分析：公司亮點、產品系列、關鍵特性、財務表現和策略。本次調查涵蓋的主要公司包括：默克集團 (Merck KGaA)、OriGene Technologies, Inc.、賽默飛世爾科技 (Thermo Fisher Scientific Inc.)、Feldan Therapeutics、ACROBiosystems、Abcam plc.、Randox Laboratories Ltd.、SOL GRONZ、Proteintech, Inc.N. Genetics、金斯瑞生物 (GenScript)、BTL Biotechno Labs Pvt Ltd.、Prospec-Tany Technogene Ltd.、BPS Bioscience, Inc.、Sino Biological、Cape Bio Pharms 和 Abnova Corporation。其中包括 GeNext Genomics 等公司。
• 本報告中的見解將使各公司的行銷負責人和經營團隊能夠就未來的產品發布、產品改進、市場擴張和行銷策略做出明智的決策。
• 這份全球重組蛋白市場報告旨在為產業內的各種相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 透過分析全球重組蛋白市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
  • 抑制因子
  • 市場吸引力分析
  • 市場機遇
• 產品發布
• 併購和合作
• 監管準則與合規性
• 政府干涉
• PEST分析
• 科技趨勢
• 品牌屬性映射
• 投資
• 價格分析（2022）

第4章 全球重組蛋白市場：依產品類型分類，2021-2033年

• 抗體
• 抗原
• 酵素
• 荷爾蒙
• 其他

第5章 全球重組蛋白市場：依表現系統分類，2021-2033年

• 微生物
• 植物
• 動物

第6章 全球重組蛋白市場：依應用領域分類，2021-2033年

• 藥物發現和藥物開發
• 出於研究目的
• 治療用途
• 診斷
• 其他

第7章 全球重組蛋白市場：依最終用戶分類，2021-2033年

• 生物技術和製藥公司
• 學術研究機構
• 受託研究機構
• 其他

第8章 全球重組蛋白市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲國家
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太國家
• 中東
  • GCC
  • 以色列
  • 其他中東國家
• 非洲
  • 北非
  • 中非
  • 南非

第9章 競爭情勢

• Merck KGaA
• OriGene Technologies, Inc.
• Thermo Fisher Scientific Inc.
• Feldan Therapeutics
• ACROBiosystems
• Abcam plc.
• Randox Laboratories Ltd.
• SOL GROUP
• Proteintech Group, Inc
• Planet Biotechnology, Inc.
• INFINITE ENZYMES, INC.
• ORF Genetics
• GenScript
• BTL Biotechno Labs Pvt Ltd.
• Prospec-Tany Technogene Ltd.
• BPS Bioscience, Inc.
• Sino Biological
• Cape Bio Pharms
• Abnova Corporation
• GeNext Genomics

第10章

• 調查方法
• 關於本公司

Recombinant Protein Market is estimated to be valued at USD 4,347.9 Mn in 2026 and is expected to reach USD 9,433.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 11.7% from 2026 to 2033.

A recombinant protein is a protein encoded by recombinant DNA cloned into an expression vector that supports gene expression and translation of messenger RNA. Modification of genes by recombinant DNA techniques can result in the expression of mutant proteins. Recombinant proteins are engineered forms of natural proteins that are produced in a variety of ways to increase protein production, alter genetic sequences, and produce useful commodities.

Many recombinant proteins require and provide post-translational modifications such as glycosylation, which are only available in eukaryotic, yeast, mammalian and insect cell culture systems. HEK293-derived cell lines are used for transient protein production. Currently, most recombinant therapeutic proteins are produced in mammalian cells due to their ability to produce high quality proteins similar to those in nature. In addition, many approved recombinant therapeutic proteins have been produced in E. coli due to well-characterized genetics, rapid growth, and high-yield production.

Market Dynamics

The company is focused on adopting strategies such as acquisitions and collaborations to gain strong foothold in the global market. For instance, in December, 2022, Thermo Fischer Scientific Inc. acquired PeproTech, Inc., which is a developer and manufacturer of recombinant proteins. This acquisition will help Thermo Fischer Scientific Inc. to strengthen its recombinant proteins portfolio.

The increasing approvals for the biologics license application of recombinant hormones from the regulatory bodies is expected to drive the market growth over the forecast period. For instance, in January 2022, Pfizer Inc., a multinational pharmaceutical and biotechnology Company, and OPKO Health, Inc., a biotechnology company, announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for somatrogon. Somatrogon is an investigational once-weekly long-acting recombinant human growth hormone for the treatment of growth hormone deficiency (GHD) in pediatric patients.

Key features of the study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global recombinant protein market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include Merck KGaA, OriGene Technologies, Inc., Thermo Fisher Scientific Inc., Feldan Therapeutics, ACROBiosystems, Abcam plc., Randox Laboratories Ltd., SOL GROUP, Proteintech Group, Inc, Planet Biotechnology, Inc., INFINITE ENZYMES, INC., ORF Genetics, GenScript, BTL Biotechno Labs Pvt Ltd., Prospec-Tany Technogene Ltd., BPS Bioscience, Inc., Sino Biological, Cape Bio Pharms, Abnova Corporation, GeNext Genomics.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global recombinant protein market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global recombinant protein market.

Market Segmentation

• Global Recombinant Protein Market, By Product Type (Revenue, USD Mn, 2021 - 2033)
• Antibodies
• Antigens
• Enzymes
• Hormones
• Others
• Global Recombinant Protein Market, By Expression System (Revenue, USD Mn, 2021 - 2033)
• Microbes
• Plant
• Animal
• Global Recombinant Protein Market By Application (Revenue, USD Mn, 2021 - 2033)
• Drug Discovery and Development
• Research Application
• Therapeutic Use
• Diagnostics
• Others
• Global Recombinant Protein Market By End User (Revenue, USD Mn, 2021 - 2033)
• Biotechnology and Pharmaceutical Companies
• Academic and Research Institute
• Contract Research Organization
• Others
• Global Recombinant Protein Market, By Region (Revenue, USD Mn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
• Merck KGaA
• OriGene Technologies, Inc.
• Thermo Fisher Scientific Inc.
• Feldan Therapeutics
• ACROBiosystems
• Abcam plc.
• Randox Laboratories Ltd.
• SOL GROUP
• Proteintech Group, Inc
• Planet Biotechnology, Inc.
• INFINITE ENZYMES, INC.
• ORF Genetics
• GenScript
• BTL Biotechno Labs Pvt Ltd.
• Prospec-Tany Technogene Ltd.
• BPS Bioscience, Inc.
• Sino Biological
• Cape Bio Pharms
• Abnova Corporation
• GeNext Genomics

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Expression System
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Attractiveness Analysis
  • Market Opportunities
• Product Launches
• Merger, Acquisition, Collaborations
• Regulatory Guideline and Compliances
• Government Intervention
• PEST Analysis
• Technology Landscape
• Brand Attribute Mapping
• Investments
• Pricing Analysis (2022)

4. Global Recombinant Protein Market, By Product Type, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Antibodies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Antigens
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Enzymes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Hormones
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Recombinant Protein Market, By Expression System, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Microbes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Plant
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Animal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Recombinant Protein Market, By Application, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segments Trends
• Drug Discovery and Development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Research Application
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Therapeutic Use
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Recombinant Protein Market, By End User, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segments Trends
• Biotechnology and Pharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Academic and Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Contract Research Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Recombinant Protein Market, By Region, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2021 - 2033
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• OriGene Technologies, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Thermo Fisher Scientific Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Feldan Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• ACROBiosystems
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Abcam plc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Randox Laboratories Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• SOL GROUP
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Proteintech Group, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Planet Biotechnology, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• INFINITE ENZYMES, INC.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• ORF Genetics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• GenScript
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• BTL Biotechno Labs Pvt Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Prospec-Tany Technogene Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• BPS Bioscience, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Sino Biological
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Cape Bio Pharms
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Abnova Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• GeNext Genomics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Section

• Research Methodology
• About Us